1st Quarter - Report

SANOFI US SERVICES INC. for SANOFI US SERVICES INC

Firm
Client
Income
—
Expenses
$1,570,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

General issues related to the 340B Federal Drug Pricing Program

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
ALISON CARA BONEBRAKE —
TIMOTHY CLARK —
PATRICK MAYES MCLAIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Corporate tax reform, including Chairman Camps discussion draft legislation Tax Reform Act of 2014; a strengthened and permanent U.S. R&D tax credit; and all provisions of HR 2835 and S1647 "Restoring Access to Medication Act of 2013"

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
PATRICK MAYES MCLAIN —
ANN TAYLOR —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2835 (113th)

Copyright/Patent/Trademark CPT

International intellectual property issues

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
SEAN CALLINICOS —
PATRICK MAYES MCLAIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Economics/Economic Development ECN

All provisions of HR 2052 and S 1023 "Global Investment in American Jobs Act of 2013"

Foreign entity interest: Sanofi SA, the foreign parent corporation of Sanofi US Services Inc.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
PATRICK MAYES MCLAIN —
ANN TAYLOR —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2052 (113th)

Health Issues HCR

Education and awareness of the 2013-2014 influenza season; education and awareness of pandemic and biodefense funding, including policy ramifications of recent BARDA contract awards; education and awareness of Dengue; S1871 "Sustainable Growth Rate (SGR) Repeal and Medicare Beneficiary Access Improvement Act of 2013"; and all provisions of HR1024 a "Medication Therapy Management Empowerment Act of 2013"; all provisions of HR3890 and S1932 "Better Care, Lower Cost Act"; issues related to thecontinued over-the-counter availability of allergy, cough and cold medicines that contain pseudoephedrine; general issues related to FDA and NIH funding; all provisions of HR 2985 "Combination Drug Development Incentive Act of 2013"; and awareness and education about Sanofi's Access to Medicines Program

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
ALISON CARA BONEBRAKE New U.S. Senator Bob Graham (1/2001 - 8/2001)
SEAN CALLINICOS —
TIMOTHY CLARK —
MARYANNE DOLBEARE DUNLAP —
PATRICK MAYES MCLAIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3890 (113th), H.R. 2985 (113th), H.R. 1024 (113th)

Medicare/Medicaid MMM

Issues related to the Medicaid rebate policy; coverage and reimbursement for the Medicare Part D prescription drug benefit and the Medicare Part D annual call letter; general issues related to reform of the Medicare Part D program; and issues related to the Medicare Part B reimbursement of prescription drugs.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
ALISON CARA BONEBRAKE —
SEAN CALLINICOS —
TIMOTHY CLARK —
MARYANNE DOLBEARE DUNLAP —
PATRICK MAYES MCLAIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

The scoring of preventive health savings including all provisions of S1422 and HR 2663 "Preventative Health Savings Act"

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
TIMOTHY CLARK —
PATRICK MAYES MCLAIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2663 (113th)

Animals ANI

Education and awareness regarding illegal compounding of veterinary drugs for animals

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
MARYANNE DOLBEARE DUNLAP —
PATRICK MAYES MCLAIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Affiliated organisations

OrganisationLocation
SANOFI PASTEUR Swiftwater, PA, US

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.